
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+2
ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCodes selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver
Rna therapies,genetic medicines,non-viral lipid nanoparticles,genetic respiratory disease,cystic fibrosis,primary ciliary dyskinesia,and biotechnology
Recode therapeutics operates in the Biotechnology research industry.
Recode therapeutics's revenue is 11m - 100m
Recode therapeutics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.